Precipio: Management Dreams Big, Institutions Have A Toe In (NASDAQ:PRPO)
· seekingalpha.com
Precipio (PRPO) stock update: razor/razor-blades cancer diagnostics, insider + Vanguard/BlackRock ownership, breakeven cash flow, 30% growth.
Precipio ( PRPO ) is a small specialty lab that has spent years developing its product and issuing shares to fund that effort. In 2025 it crossed into positive ...